Melanoma and Non-melanoma Skin Cancer: Cellular Mechanisms, Immunity and Therapeutics
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: closed (15 June 2024) | Viewed by 1466
Special Issue Editor
Interests: dermal stem cells; skin immunity; ABC transporters; ABCB5; melanoma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite major advances in gene- and immune-targeted therapies, melanoma and non-melanoma skin cancers, once metastasized, remain largely refractory to cures. However, the advent of single-cell omics technologies for cancer characterization, including whole-genome mutational analyses, RNA sequencing, and epigenetic analyses, has recently opened up unprecedented opportunities for the discovery of novel targetable molecular cancer pathways, and hence the development of novel strategies for tumor eradication. This Special Issue aims to present cutting-edge research in the fields of melanoma and non-melanoma skin cancer biology, including the molecular and cellular mechanisms of cancer initiation, immune evasion, cancer plasticity, and metastasis. Moreover, manuscript submissions presenting novel insights into skin cancer therapeutic resistance or exploring potential skin cancer therapeutic approaches are encouraged.
We cordially invite you to contribute your original research to this exciting Special Issue of Cells.
Dr. Markus Frank
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- melanoma
- squamous cell carcinoma
- Merkel cell carcinoma
- tumorigenicity
- metastasis
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
